Alesco Advisors LLC An ESL Co Takes $828,000 Position in The Cooper Companies, Inc. $COO

Alesco Advisors LLC An ESL Co acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the first quarter, Holdings Channel reports. The firm acquired 11,575 shares of the medical device company’s stock, valued at approximately $828,000.

Several other large investors have also recently added to or reduced their stakes in the business. DAVENPORT & Co LLC boosted its position in Cooper Companies by 1,359.7% in the 4th quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock valued at $46,642,000 after buying an additional 528,346 shares during the period. Fluent Financial LLC purchased a new stake in shares of Cooper Companies during the fourth quarter worth $3,517,000. Heartland Advisors Inc. acquired a new stake in shares of Cooper Companies in the fourth quarter valued at $15,348,000. Wealth Enhancement Advisory Services LLC boosted its holdings in Cooper Companies by 212.3% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 31,455 shares of the medical device company’s stock valued at $2,652,000 after purchasing an additional 21,383 shares during the period. Finally, Assetmark Inc. boosted its holdings in Cooper Companies by 21.0% in the fourth quarter. Assetmark Inc. now owns 184,410 shares of the medical device company’s stock valued at $15,114,000 after purchasing an additional 31,980 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Stifel Nicolaus lowered their price objective on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 target price on shares of Cooper Companies in a research note on Wednesday, May 27th. Mizuho set a $85.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a report on Thursday, June 4th. Finally, Citigroup reiterated a “neutral” rating and issued a $76.00 price target (up from $69.00) on shares of Cooper Companies in a research note on Wednesday, July 8th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $81.85.

Cooper Companies Stock Down 0.8%

Shares of NASDAQ COO opened at $71.01 on Wednesday. The business has a 50-day moving average of $66.71 and a two-hundred day moving average of $72.36. The company has a market capitalization of $13.85 billion, a price-to-earnings ratio of 60.18, a price-to-earnings-growth ratio of 1.87 and a beta of 0.84. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.